Skip to main content
    H

    Harmony Biosciences Holdings (HRMY)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $32.96
    -0.80 (-2.37%)

    Market Cap: $1.94B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Harmony Biosciences Holdings (HRMY) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Harmony Biosciences Holdings (HRMY) has a latest price of $32.96 on Nov 17, 2026, 24.2% below its 52-week high of $43.49. Its price fell 3.9% over the past 12 months. The month-end price fell 6.5% over the 5 years through Oct 2026, a compound annual decline of 1.3%.

    Price Chart

    From Aug 2020 to Oct 2026, its highest month-end close was $59.77 in Nov 2022 and its lowest $23.54 in Oct 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart HRMY with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for HRMY.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 15.1%, and over 6 months it rose 10.5%. The month-end price rose 64.7% over the 3 years through Oct 2026, a compound annual rate of 18.1%.

    PeriodChange
    1 month-13.1%
    3 months-15.1%
    6 months+10.5%
    12 months-3.9%
    12 months, with dividends-3.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+64.7%+18.1%
    5 years-6.5%-1.3%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2022, when the price rose 29.2%, and its weakest was 2023, when it fell 41.4%.

    YearCloseChange
    2026 through Oct 2026$38.76+3.6%
    2025$37.42+8.7%
    2024$34.41+6.5%
    2023$32.30-41.4%
    2022$55.10+29.2%
    2021$42.64+18.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 14.3% below its 50-day average of $38.46 and 4.6% below its 200-day average of $34.55.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$32.96
    52-week high$43.49-24.2%
    52-week low$25.90+27.3%
    50-day average$38.46-14.3%
    200-day average$34.55-4.6%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 37.6%.

    MeasureValue
    1-year beta0.64
    Largest fall, 1 year-34.5%
    Largest fall, 3 years-37.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Harmony Biosciences Holdings traded at 11.2x earnings at the end of 2025, against a 5-year median of 10.9x.

    HRMY valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About HRMY

    What is HRMY's 1-year price change?

    Harmony Biosciences Holdings's price fell 3.9% over the past 12 months. With dividends included, the 12-month total return was -3.9%.

    What is HRMY's 5-year price change?

    Harmony Biosciences Holdings's month-end price fell 6.5% over the 5 years through Oct 2026, a compound annual decline of 1.3%. These figures leave out dividends.

    What is HRMY's 52-week high and low?

    Harmony Biosciences Holdings's 52-week high is $43.49 and its 52-week low is $25.90. Its latest price of $32.96 on Nov 17, 2026 is 24.2% below the high.

    What is HRMY's beta?

    Harmony Biosciences Holdings's 1-year beta against the S&P 500 is 0.64, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 34.5%.

    Is the HRMY chart free?

    Yes. Advanced Charting for HRMY is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.